Microtubule-Associated Protein tau (MAPT) (Middle Region) Peptide
MAPT
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MAPT products
- MAPT (Microtubule-Associated Protein tau (MAPT))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- NAKAKTDHGA EIVYKSPVVS GDTSPRHLSN VSSTGSIDMV DSPQLATLAD
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MAPT Antibody(ARP48104_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MAPT (Microtubule-Associated Protein tau (MAPT))
- Synonyms
- DDPAC Peptide, FTDP-17 Peptide, MAPTL Peptide, MSTD Peptide, MTBT1 Peptide, MTBT2 Peptide, PPND Peptide, TAU Peptide, AI413597 Peptide, AW045860 Peptide, Mtapt Peptide, Tau Peptide, RNPTAU Peptide, pTau Peptide, tau Peptide, xtp Peptide, MAPT Peptide, PHF-tau Peptide, slc6a6 Peptide, taut Peptide, wu:fc26e12 Peptide, microtubule associated protein tau Peptide, microtubule-associated protein tau Peptide, microtubule associated protein tau S homeolog Peptide, Microtubule-associated protein tau Peptide, solute carrier family 6 (neurotransmitter transporter), member 6b Peptide, MAPT Peptide, Mapt Peptide, mapt.S Peptide, LOC5580230 Peptide, CpipJ_CPIJ013260 Peptide, tau Peptide, slc6a6b Peptide
- Background
-
MAPT is differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. The mutations in the gene have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
Alias Symbols: DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, TAU
Protein Interaction Partner: YWHAZ,GSK3B,AATF,ABL1,ACTB,APOE,ARHGEF40,CALM1,CAMK2A,CASP1,CASP3,CASP6,CASP7,CASP8,CDK1,CDK5,CDK5,CDK5,FYN,GSK3A,GSK3B,HSPA8,MAPK12,MAPT,MARK1,MARK4,OGT,PHKG1,PIN1,PKN1,PPP2CA,PPP2CB,PPP2R5A,PPP5C,PRKCD,PSEN1,RPS6KA3,RPS6KB1,S100B,SNCA,SPTB,STAU1,STUB1,S
Protein Size: 383 - Molecular Weight
- 40 kDa
- Gene ID
- 4137
- NCBI Accession
- NM_016834, NP_058518
-
You are here:
